Is it appropriate to use Pediapred (prednisolone oral solution) for treating influenza in infants?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pediapred Should NOT Be Used for Influenza in Infants

Corticosteroids like Pediapred (prednisolone) are contraindicated for treating influenza in infants and should be avoided. The evidence consistently demonstrates harm rather than benefit, and current guidelines explicitly recommend against their use.

Why Corticosteroids Are Harmful in Influenza

The most recent WHO clinical practice guidelines (2024) and AAP recommendations (2025-2026) make conditional recommendations AGAINST corticosteroid use in severe influenza 1, 2, 3. This is based on substantial evidence showing:

  • Increased mortality: Meta-analyses demonstrate corticosteroid therapy is associated with significantly increased death rates (OR 3.90,95% CI 2.31-6.60) and adjusted hazard ratios showing 49% increased mortality risk 4, 5
  • Higher infection rates: Hospital-acquired infections increase nearly 3-fold (OR 2.74,95% CI 1.51-4.95) with corticosteroid use 4
  • Prolonged illness: Mechanical ventilation duration increases by 3.82 days and ICU stays lengthen by 4.78 days 6
  • Delayed viral clearance: Corticosteroids impair the body's ability to eliminate influenza virus 7

These findings are consistent across multiple systematic reviews spanning 2015-2025 4, 5, 6, 7.

What Should Be Used Instead

Oseltamivir is the preferred antiviral for infants with influenza 8, 9. The AAP and CDC guidelines specify:

For Infants (Birth to <12 months):

  • Term infants: Oseltamivir is FDA-approved from 2 weeks of age and can be used from birth based on pharmacokinetic data showing benefits outweigh risks 8, 9
  • Dosing varies by age:
    • 0-8 months: 3.0 mg/kg twice daily
    • 9-11 months: 3.5 mg/kg twice daily (higher than FDA-approved dose, based on AAP data) 9
  • Preterm infants: Lower weight-based dosing using postmenstrual age; consult pediatric infectious disease for extremely preterm infants (<28 weeks) 9

Treatment Indications for Infants:

Antiviral treatment should be started as early as possible (ideally within 48 hours, but no time limit for severe cases) for 8, 9:

  • Any hospitalized infant with suspected/confirmed influenza
  • Any infant with severe, complicated, or progressive disease
  • All infants <5 years are considered high-risk and should receive treatment regardless of severity

Critical Distinction: COVID-19 vs. Influenza

A crucial pitfall to avoid: corticosteroids show benefit in severe COVID-19 but cause harm in influenza 7, 10. The RECOVERY trial demonstrated dexamethasone reduces mortality in severe COVID-19, but this finding does NOT apply to influenza. The opposing outcomes reflect distinct immunopathological mechanisms between these viral infections 7.

Pediapred-Specific Concerns in Infants

The FDA label for Pediapred highlights additional pediatric safety concerns 11:

  • Growth suppression: Even low systemic doses can decrease growth velocity in children, often without laboratory evidence of HPA axis suppression
  • Immunosuppression: Diminished response to vaccines and increased risk of infection from live attenuated vaccines
  • Multiple adverse effects: Increased risk of infections, metabolic disturbances, and other complications that are particularly concerning in the vulnerable infant population

Bottom Line Algorithm

For any infant with suspected or confirmed influenza:

  1. Start oseltamivir immediately (age-appropriate dosing)
  2. Do NOT give corticosteroids (including Pediapred)
  3. Consider hospitalization if <5 years with any concerning features
  4. Test with RT-PCR or NAAT if hospitalized 9
  5. Monitor for bacterial superinfection (antibiotics only if documented bacterial co-infection) 8

The evidence is clear and consistent: corticosteroids worsen outcomes in influenza across all age groups, and this is especially critical to avoid in vulnerable infant populations.

References

Research

[WHO clinical practice guidelines for influenza: an update].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)), 2025

Research

Summary of WHO clinical practice guidelines for influenza.

BMJ (Clinical research ed.), 2026

Research

Corticosteroids as adjunctive therapy in the treatment of influenza.

The Cochrane database of systematic reviews, 2019

Research

Corticosteroids for the treatment of human infection with influenza virus: a systematic review and meta-analysis.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2015

Related Questions

Should prednisone be used for uncomplicated influenza, and if indicated, what is the appropriate dosage and duration?
I have confirmed influenza and am allergic to oseltamivir (Tamiflu); can a corticosteroid be used to treat my flu?
What is the appropriate acute management for a 63-year-old man with a two‑day history of severe cough causing incontinence, left‑upper‑apical expiratory wheezing, afebrile status, respiratory rate 18 breaths per minute, oxygen saturation 96%, heart rate 107 beats per minute, blood pressure 132/62 mmHg, previously diagnosed with influenza and prescribed an inhaler, presenting to urgent care for the first time?
What is the appropriate management for a 4.5-year-old female child presenting with fever up to 101 °F, chills, dry cough, nasal congestion, and influenza?
What is the recommended evaluation and management for a 52-year-old man presenting with a high fever (103.3 °F) and influenza‑like illness for one week with worsening weakness?
Is a once‑daily dose of acyclovir 800 mg appropriate for treating HSV‑1 whitlow in a patient with normal renal function?
What is the recommended treatment for mild osteoarthritis?
What are the optimal centrifugation techniques for preparing platelet‑rich plasma (PRP)?
What is the recommended body mass index for a 79-year-old male?
Should prednisone be used for uncomplicated influenza, and if indicated, what is the appropriate dosage and duration?
How should inability to void be managed in a patient undergoing dialysis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.